Combination of <i>Helicobacter pylori</i> Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study-Reference-Cited by-同舟云学术

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study

Published:2016 Issue:12 Volume:26 Page:629-636
ISSN:0917-5040
Container-title:Journal of Epidemiology
language:en
Short-container-title:Journal of Epidemiology

Author:

Ikeda Fumie¹²³,Shikata Kentaro¹²,Hata Jun¹²³,Fukuhara Masayo¹²,Hirakawa Yoichiro¹²,Ohara Tomoyuki¹⁴,Mukai Naoko¹²³,Nagata Masaharu¹²,Yoshida Daigo¹³,Yonemoto Koji⁵,Esaki Motohiro²,Kitazono Takanari²³,Kiyohara Yutaka¹³,Ninomiya Toshiharu¹²³

Affiliation:

1. Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University

2. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University

3. Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University

4. Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University

5. Biostatistics Center, Kurume University

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science, and Technology

Ministry of Health, Labour and Welfare

Publisher

Japan Epidemiological Association

Subject

General Medicine,Epidemiology

Link

https://www.jstage.jst.go.jp/article/jea/26/12/26_JE20150258/_pdf

Reference46 articles.

1. 1. International Agency for Research on Cancer. IRAC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 61. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: IARC press; 1994.

2. 2. Yamagata H, Kiyohara Y, Aoyagi K, Kato I, Iwamoto H, Nakayama K, et al. Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama Study. Arch Intern Med. 2000;160:1962–8.

3. 3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.

4. 4. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.

5. 5. Walker IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut. 1971;12:906–11.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Prediction Models for Gastric Cancer: A Scoping Review;Journal of Multidisciplinary Healthcare;2024-09

2. Chilean consensus by expert panel using the Delphi technique for primary and secondary prevention of gastric cancer;Gastroenterología y Hepatología (English Edition);2024-08

3. Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis;Journal of Translational Medicine;2024-05-06

4. Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer;Gastric Cancer;2024-04-07

5. Risk Factors for Developing Metachronous Superficial Gastric Epithelial Neoplasms after Endoscopic Submucosal Dissection;Journal of Clinical Medicine;2024-03-10